113 related articles for article (PubMed ID: 18973858)
1. Comparison of traditional and simultaneous IMRT boost technique basing on therapeutic gain calculation.
Slosarek K; Zajusz A; Szlag M
Med Dosim; 2008; 33(4):299-302. PubMed ID: 18973858
[TBL] [Abstract][Full Text] [Related]
2. Normal tissue complication probability: does simultaneous integrated boost intensity-modulated radiotherapy score over other techniques in treatment of prostate adenocarcinoma.
Basu KS; Bahl A; Subramani V; Sharma DN; Rath GK; Julka PK
J Cancer Res Ther; 2009; 5(2):78-84. PubMed ID: 19542662
[TBL] [Abstract][Full Text] [Related]
3. Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review.
Orlandi E; Palazzi M; Pignoli E; Fallai C; Giostra A; Olmi P
Crit Rev Oncol Hematol; 2010 Feb; 73(2):111-25. PubMed ID: 19409808
[TBL] [Abstract][Full Text] [Related]
4. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult.
Ho KF; Fowler JF; Sykes AJ; Yap BK; Lee LW; Slevin NJ
Acta Oncol; 2009; 48(3):431-9. PubMed ID: 18781445
[TBL] [Abstract][Full Text] [Related]
5. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
6. Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.
Hoffmann AL; den Hertog D; Siem AY; Kaanders JH; Huizenga H
Phys Med Biol; 2008 Nov; 53(22):6345-62. PubMed ID: 18941280
[TBL] [Abstract][Full Text] [Related]
7. Volumetric modulated Arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: a planning comparison study.
Shaffer R; Morris WJ; Moiseenko V; Welsh M; Crumley C; Nakano S; Schmuland M; Pickles T; Otto K
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):401-7. PubMed ID: 19268554
[TBL] [Abstract][Full Text] [Related]
8. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?
Sanguineti G; Endres EJ; Gunn BG; Parker B
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):931-8. PubMed ID: 17011465
[TBL] [Abstract][Full Text] [Related]
9. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cervical esophagus dose-volumes for three radiotherapy techniques for head and neck cancer.
Chen J; Shrieve DC; Hitchcock YJ
Radiother Oncol; 2008 May; 87(2):274-80. PubMed ID: 18206257
[TBL] [Abstract][Full Text] [Related]
11. Volumetric-modulated arc radiotherapy for carcinomas of the anal canal: A treatment planning comparison with fixed field IMRT.
Clivio A; Fogliata A; Franzetti-Pellanda A; Nicolini G; Vanetti E; Wyttenbach R; Cozzi L
Radiother Oncol; 2009 Jul; 92(1):118-24. PubMed ID: 19181409
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
13. Validation of temporal optimization effects for a single fraction of radiation in vitro.
Altman MB; Stinauer MA; Javier D; Smith BD; Herman LC; Pytynia ML; Aydogan B; Pelizzari CA; Chmura SJ; Roeske JC
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1240-6. PubMed ID: 19857787
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
Kassim I; Dirkx ML; Heijmen BJ
Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison between 3DCRT and IMRT using different multileaf collimators in the treatment of brain tumors.
Ding M; Newman F; Chen C; Stuhr K; Gaspar LE
Med Dosim; 2009; 34(1):1-8. PubMed ID: 19181248
[TBL] [Abstract][Full Text] [Related]
16. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
Grégoire V
Rays; 2005; 30(2):105-8. PubMed ID: 16294902
[TBL] [Abstract][Full Text] [Related]
17. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.
St-Hilaire J; Sévigny C; Beaulieu F; Germain F; Lavoie C; Dagnault A; Gingras L; Tremblay D; Beaulieu L
Radiother Oncol; 2009 Jun; 91(3):342-8. PubMed ID: 19135749
[TBL] [Abstract][Full Text] [Related]
18. Optimization of the temporal pattern of radiation: an IMRT based study.
Altman MB; Chmura SJ; Deasy JO; Roeske JC
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):898-905. PubMed ID: 17011463
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.
Mohan R; Wu Q; Manning M; Schmidt-Ullrich R
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):619-30. PubMed ID: 10701741
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling.
Fowler JF
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1532-7. PubMed ID: 19306749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
